News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,179 Results
Type
Article (42921)
Company Profile (295)
Press Release (676963)
Multimedia
Podcasts (81)
Webinars (12)
Section
Business (210543)
Career Advice (2092)
Deals (36639)
Drug Delivery (107)
Drug Development (83168)
Employer Resources (175)
FDA (16595)
Job Trends (15429)
News (356272)
Policy (33956)
Tag
Academia (2606)
Accelerated approval (5)
Adcomms (21)
Allergies (92)
Alliances (51488)
ALS (97)
Alzheimer's disease (1405)
Antibody-drug conjugate (ADC) (138)
Approvals (16593)
Artificial intelligence (276)
Autoimmune disease (24)
Automation (16)
Bankruptcy (371)
Best Places to Work (11783)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (189)
Bladder cancer (78)
Brain cancer (29)
Breast cancer (292)
Cancer (2344)
Cardiovascular disease (188)
Career advice (1753)
Career pathing (31)
CAR-T (155)
Cell therapy (440)
Cervical cancer (20)
Clinical research (67652)
Collaboration (876)
Company closure (2)
Compensation (563)
Complete response letters (25)
COVID-19 (2720)
CRISPR (47)
C-suite (257)
Cystic fibrosis (105)
Data (2312)
Decentralized trials (2)
Denatured (29)
Depression (47)
Diabetes (279)
Diagnostics (6477)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (114)
Drug shortages (28)
Duchenne muscular dystrophy (97)
Earnings (88643)
Editorial (39)
Employer branding (21)
Employer resources (149)
Events (115536)
Executive appointments (753)
FDA (17968)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (776)
Gene editing (116)
Generative AI (21)
Gene therapy (326)
GLP-1 (758)
Government (4563)
Grass and pollen (6)
Guidances (140)
Healthcare (19028)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (129)
Indications (30)
Infectious disease (2868)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (99)
Interviews (323)
IPO (16802)
IRA (47)
Job creations (4062)
Job search strategy (1492)
Kidney cancer (10)
Labor market (42)
Layoffs (496)
Leadership (18)
Legal (8384)
Liver cancer (77)
Lung cancer (327)
Lymphoma (158)
Machine learning (9)
Management (59)
Manufacturing (336)
MASH (73)
Medical device (13475)
Medtech (13480)
Mergers & acquisitions (20399)
Metabolic disorders (725)
Multiple sclerosis (82)
NASH (17)
Neurodegenerative disease (96)
Neuropsychiatric disorders (29)
Neuroscience (1974)
NextGen: Class of 2025 (6639)
Non-profit (4531)
Now hiring (40)
Obesity (386)
Opinion (229)
Ovarian cancer (79)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (152)
Partnered (21)
Patents (247)
Patient recruitment (116)
Peanut (49)
People (59342)
Pharmaceutical (91)
Pharmacy benefit managers (20)
Phase I (20991)
Phase II (29768)
Phase III (22298)
Pipeline (1337)
Policy (159)
Postmarket research (2656)
Preclinical (8952)
Press Release (68)
Prostate cancer (108)
Psychedelics (31)
Radiopharmaceuticals (251)
Rare diseases (401)
Real estate (6259)
Recruiting (67)
Regulatory (23192)
Reports (47)
Research institute (2383)
Resumes & cover letters (358)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (78)
Series A (134)
Series B (88)
Service/supplier (12)
Sickle cell disease (55)
Special edition (16)
Spinal muscular atrophy (150)
Sponsored (31)
Startups (3733)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (51)
The Weekly (50)
Vaccines (742)
Venture capitalists (42)
Weight loss (256)
Women's health (35)
Worklife (16)
Date
Today (222)
Last 7 days (927)
Last 30 days (3094)
Last 365 days (33172)
2025 (11769)
2024 (35796)
2023 (40659)
2022 (51858)
2021 (56419)
2020 (54821)
2019 (47429)
2018 (35791)
2017 (33160)
2016 (32704)
2015 (38635)
2014 (32550)
2013 (27664)
2012 (29772)
2011 (30531)
2010 (28540)
Location
Africa (783)
Alabama (53)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (40804)
Australia (6531)
California (6386)
Canada (2067)
China (548)
Colorado (275)
Connecticut (278)
Delaware (159)
Europe (87307)
Florida (943)
Georgia (211)
Idaho (57)
Illinois (559)
India (26)
Indiana (327)
Iowa (11)
Japan (175)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (925)
Massachusetts (4771)
Michigan (225)
Minnesota (403)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (63)
New Jersey (1795)
New Mexico (29)
New York (1799)
North Carolina (1004)
North Dakota (8)
Northern California (2803)
Ohio (208)
Oklahoma (14)
Oregon (39)
Pennsylvania (1425)
Puerto Rico (13)
Rhode Island (33)
South America (1164)
South Carolina (25)
South Dakota (1)
Southern California (2402)
Tennessee (105)
Texas (952)
United States (24035)
Utah (190)
Virginia (160)
Washington D.C. (64)
Washington State (570)
West Virginia (3)
Wisconsin (59)
720,179 Results for "variant pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
April 1, 2025
·
11 min read
Press Releases
Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
April 25, 2025
·
6 min read
Press Releases
Dovetail Genomics Unveils Ultra-Sensitive Somatic Variant Detection and AI-Driven Analysis Ahead of AACR 2025
April 23, 2025
·
4 min read
Press Releases
Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants
March 26, 2025
·
11 min read
Press Releases
Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application
February 20, 2025
·
5 min read
Press Releases
Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect
March 25, 2025
·
8 min read
Genetown
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants
Invivyd, Inc. announced that VYD222, a half-life extended investigational monoclonal antibody, shows continued in vitro neutralization activity in pseudovirus assays designed to represent the predominant emerging variants of SARS-CoV-2, including the KP.1.1 FLiRT and KP.3 variants.
June 14, 2024
·
7 min read
Press Releases
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
March 6, 2025
·
13 min read
Press Releases
BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions
March 25, 2025
·
3 min read
ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody Against the SARS-CoV-2 Variant JN.1
ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious diseases, announced new data demonstrating that its antibodies are exceptionally potent in neutralizing the SARS-CoV-2 variant JN.1, the parental strain of the currently most dominantly circulating variants worldwide.
June 4, 2024
·
4 min read
1 of 72,018
Next
